Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qt Imaging Holdings (QTI) Change in Receivables (2023 - 2026)

Qt Imaging Holdings (QTI) reported Change in Receivables of $572000.0 for Q1 2026, down 78.93% year-over-year from $2.7 million in Q1 2025, and down 77.46% on a QoQ basis from $2.5 million in Q4 2025.

Qt Imaging Holdings (QTI) has 4 years of Change in Receivables data on file, last reported at $572000.0 in Q1 2026.

  • Quarterly Change in Receivables fell 78.93% year-over-year to $572000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 55.28% YoY) and the FY2025 annual result came in at $5.7 million, up 8428.36% from the prior year.
  • Change in Receivables slipped to $572000.0 in Q1 2026 per QTI's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $2.7 million in Q1 2025 and bottomed at -$412252.0 in Q3 2024.
  • The 4-year median for Change in Receivables is $18511.0 (2023), against an average of $488791.5.
  • Peak annual rise in Change in Receivables reached 8159.54% in 2024, while the deepest fall reached 2327.06% in 2024.
  • Tracing QTI's Change in Receivables over 4 years: stood at -$17221.0 in 2023, then plunged by 1002.64% to -$189886.0 in 2024, then jumped by 1436.28% to $2.5 million in 2025, then sank by 77.46% to $572000.0 in 2026.
  • Per Business Quant, the three latest QTI Change in Receivables figures stand at $572000.0 (Q1 2026), $2.5 million (Q4 2025), and -$407604.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 42.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -444.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -13.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 117.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 117.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -124.60 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -141.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 123.50 Mn
10 Qt Imaging Holdings 67.06 Mn 67.06 Mn 2.67 Mn 572,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 572,000.00
Mar 31, 2026 572,000.00
Dec 31, 2025 2.54 Mn
Dec 31, 2025 2.54 Mn
Sep 30, 2025 -407,604.00
Sep 30, 2025 -407,604.00
Jun 30, 2025 869,191.00
Jun 30, 2025 869,191.00
Mar 31, 2025 2.72 Mn
Mar 31, 2025 2.72 Mn
Dec 31, 2024 -189,886.00
Dec 31, 2024 -189,886.00
Sep 30, 2024 -412,252.00
Sep 30, 2024 -412,252.00
Jun 30, 2024 186,781.00
Jun 30, 2024 186,781.00
Mar 31, 2024 482,357.00
Mar 31, 2024 482,357.00
Dec 31, 2023 -17,221.00
Dec 31, 2023 -17,221.00
Sep 30, 2023 18,511.00
Sep 30, 2023 18,511.00
Jun 30, 2023 -5,840.00
Jun 30, 2023 -5,840.00
Mar 31, 2023 5,840.00
Mar 31, 2023 5,840.00